Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip (TA304)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 February 2014
Secukinumab for treating relapsed polymyalgia rheumatica ID6599Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC